Literature DB >> 12953031

Convection versus diffusion in dialysis: an Italian prospective multicentre study.

Piergiorgio Bolasco1, Paolo Altieri, Simeone Andrulli, Carlo Basile, Salvatore Di Filippo, Mariano Feriani, Luciano Pedrini, Antonio Santoro, Carmine Zoccali, Giovanna Sau, Francesco Locatelli.   

Abstract

The concept of dialysis adequacy has to be widened to include medium size and large molecule removal in addition to urea kinetics. The HEMO study found a non-significant trend toward a beneficial effect on mortality of high-flux dialysis compared with low-flux dialysis. In that study, the beneficial effect of convection could have been attenuated by the fact that 'internal filtration' in high-flux haemodialysis (HD) is lower than that expected by convection in haemofiltration (HF) or haemodiafiltration (HDF). To explore the putative beneficial effect of convection, this Italian multicentre study was planned, comparing on-line convective treatments (HF and HDF) with standard, low-flux HD. The enrolled patients will be evaluated prospectively on their usual treatment for 2 months (baseline period) and subsequently randomized to continue either with low-flux HD (50%) or to start on-line convective treatment (50%), HF or HDF according to a 1:1 ratio. The primary end point of the study will be cardiovascular stability and blood pressure control. As secondary aims of the study, the impact on symptoms, morbidity and mortality will be assessed. Feasibility and patient compliance during HF and HDF treatments will also be evaluated. The experimental phase of the study, of at least 2 years, is divided into a 3-month adaptation period and a subsequent evaluation period. A recruitment period of 1 year is planned. The study design has adequate power to detect an absolute reduction of 3% hypotensive episodes with the experimental convective treatments compared with standard low-flux HD.

Entities:  

Mesh:

Year:  2003        PMID: 12953031     DOI: 10.1093/ndt/gfg1080

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Piergiorgio Bolasco; Giovanna Sau; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Giovanni Montagna; Biagio Raffaele Di Iorio; Bruno Memoli; Raffaella Cravero; Giovanni Battaglia; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

2.  Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis.

Authors:  Enric Vilar; Andrew C Fry; David Wellsted; James E Tattersall; Roger N Greenwood; Ken Farrington
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

3.  Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Giovanna Sau; Piergiorgio Bolasco; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Pier Eugenio Nebiolo; Rocco Ferrara; Domenica Casu; Francesco Logias; Renzo Tarchini; Francesco Cadinu; Mario Passaghe; Gianfranco Fundoni; Giuseppe Villa; Biagio Raffaele Di Iorio; Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2012-05-23       Impact factor: 5.992

4.  Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities.

Authors:  Pasquale Esposito; Edoardo La Porta; Marta Calatroni; Maria Antonietta Grignano; Samantha Milanesi; Daniela Verzola; Yuri Battaglia; Marilena Gregorini; Carmelo Libetta; Giacomo Garibotto; Teresa Rampino
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.